VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q117223896 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000000.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q117223896‏
035 ‎‡a (OCoLC)Q117223896‏
100 0 ‎‡a Stephanie G Sumner-Jones‏ ‎‡c researcher‏ ‎‡9 en‏
670 ‎‡a Author's A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis‏
670 ‎‡a Author's An immunocytochemical assay to detect human CFTR expression following gene transfer‏
670 ‎‡a Author's Assessment of CFTR function after gene transfer in vitro and in vivo.‏
670 ‎‡a Author's CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.‏
670 ‎‡a Author's Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.‏
670 ‎‡a Author's Enhanced Lung Gene Expression After Aerosol Delivery of Concentrated pDNA/PEI Complexes‏
670 ‎‡a Author's Limitations of the murine nose in the development of nonviral airway gene transfer.‏
670 ‎‡a Author's Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.‏
670 ‎‡a Author's Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.‏
670 ‎‡a Author's Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer.‏
670 ‎‡a Author's The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.‏
670 ‎‡a Author's The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.‏
919 ‎‡a randomiseddoubleblindplacebocontrolledtrialofrepeatednebulisationofnonviralcysticfibrosistransmembraneconductanceregulatorcftrgenetherapyinpatientswithcysticfibrosis‏ ‎‡A A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis‏ ‎‡9 1‏
919 ‎‡a useofcpgfreeplasmidstomediatepersistentgeneexpressionfollowingrepeatedaerosoldeliveryofpdnapeicomplexes‏ ‎‡A The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.‏ ‎‡9 1‏
919 ‎‡a safetyprofileofacationiclipidmediatedcysticfibrosisgenetransferagentfollowingrepeatedmonthlyaerosoladministrationtosheep‏ ‎‡A The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.‏ ‎‡9 1‏
919 ‎‡a secretedgaussialuciferaseasasensitivereportergeneforinvivoandexvivostudiesofairwaygenetransfer‏ ‎‡A Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer.‏ ‎‡9 1‏
919 ‎‡a repeatednebulisationofnonviralcftrgenetherapyinpatientswithcysticfibrosisarandomiseddoubleblindplacebocontrolledphase2btrial‏ ‎‡A Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.‏ ‎‡9 1‏
919 ‎‡a preparationfora1inmanlentivirustrialinpatientswithcysticfibrosis‏ ‎‡A Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.‏ ‎‡9 1‏
919 ‎‡a limitationsofthemurinenoseinthedevelopmentofnonviralairwaygenetransfer‏ ‎‡A Limitations of the murine nose in the development of nonviral airway gene transfer.‏ ‎‡9 1‏
919 ‎‡a enhancedlunggeneexpressionafteraerosoldeliveryofconcentratedpdnapeicomplexes‏ ‎‡A Enhanced Lung Gene Expression After Aerosol Delivery of Concentrated pDNA/PEI Complexes‏ ‎‡9 1‏
919 ‎‡a electroporationenhancesreportergeneexpressionfollowingdeliveryofnakedplasmiddnatothelung‏ ‎‡A Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.‏ ‎‡9 1‏
919 ‎‡a cpgfreeplasmidsconferreducedinflammationandsustainedpulmonarygeneexpression‏ ‎‡A CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.‏ ‎‡9 1‏
919 ‎‡a assessmentofcftrfunctionaftergenetransferinvitroandinvivo‏ ‎‡A Assessment of CFTR function after gene transfer in vitro and in vivo.‏ ‎‡9 1‏
919 ‎‡a immunocytochemicalassaytodetecthumancftrexpressionfollowinggenetransfer‏ ‎‡A An immunocytochemical assay to detect human CFTR expression following gene transfer‏ ‎‡9 1‏
996 ‎‡2 SUDOC|03164144X‏
996 ‎‡2 RERO|A003430145‏
996 ‎‡2 ISNI|0000000357535076‏
996 ‎‡2 ISNI|0000000430344015‏
996 ‎‡2 NLA|000035807752‏
996 ‎‡2 LC|n 2014005099‏
996 ‎‡2 LC|no2008094151‏
996 ‎‡2 SUDOC|142646563‏
996 ‎‡2 NUKAT|n 2008071555‏
996 ‎‡2 NUKAT|n 2005136240‏
996 ‎‡2 J9U|987007374222305171‏
996 ‎‡2 NUKAT|n 2009088913‏
996 ‎‡2 NTA|36284531X‏
996 ‎‡2 SUDOC|074716360‏
996 ‎‡2 BNF|16634431‏
996 ‎‡2 LC|n 78094790‏
996 ‎‡2 BNF|17919535‏
996 ‎‡2 BIBSYS|90246871‏
996 ‎‡2 NKC|pag2013796725‏
996 ‎‡2 SELIBR|285557‏
996 ‎‡2 ISNI|0000000036024144‏
996 ‎‡2 BIBSYS|1593520723521‏
996 ‎‡2 CAOONL|ncf10524313‏
996 ‎‡2 LC|no 93016899‏
996 ‎‡2 NKC|ntk2010537838‏
996 ‎‡2 ISNI|0000000030448886‏
996 ‎‡2 PTBNP|663548‏
996 ‎‡2 LC|n 83800066‏
996 ‎‡2 ISNI|0000000043254132‏
996 ‎‡2 ISNI|0000000116883280‏
996 ‎‡2 LC|no 00054870‏
996 ‎‡2 SUDOC|279968973‏
996 ‎‡2 J9U|987007368919805171‏
996 ‎‡2 LC|no 99022039‏
996 ‎‡2 J9U|987007452612705171‏
996 ‎‡2 ISNI|0000000039650642‏
996 ‎‡2 DNB|133470253‏
996 ‎‡2 ISNI|0000000040456927‏
996 ‎‡2 CAOONL|ncf11719458‏
996 ‎‡2 J9U|987007440145205171‏
996 ‎‡2 LC|n 2002027616‏
996 ‎‡2 BNF|12169174‏
996 ‎‡2 ISNI|0000000048388527‏
996 ‎‡2 LC|nb2007015637‏
996 ‎‡2 CAOONL|ncf12110264‏
996 ‎‡2 BIBSYS|97020206‏
996 ‎‡2 RERO|A000074448‏
996 ‎‡2 BIBSYS|7035865‏
996 ‎‡2 LC|nb2009000279‏
996 ‎‡2 SUDOC|119935945‏
996 ‎‡2 LC|n 2009070653‏
996 ‎‡2 ISNI|0000000024110889‏
996 ‎‡2 CAOONL|ncf13703678‏
996 ‎‡2 SUDOC|099036940‏
996 ‎‡2 LC|n 78037820‏
996 ‎‡2 CAOONL|ncf12104472‏
996 ‎‡2 RERO|A027360694‏
996 ‎‡2 LC|nb2003032240‏
996 ‎‡2 LC|nb2021004548‏
996 ‎‡2 NII|DA16358207‏
996 ‎‡2 ISNI|0000000079358195‏
996 ‎‡2 ISNI|000000003135593X‏
996 ‎‡2 LC|n 2005052405‏
996 ‎‡2 BIBSYS|10077443‏
996 ‎‡2 CAOONL|ncf10253654‏
996 ‎‡2 CAOONL|ncf11062374‏
996 ‎‡2 BIBSYS|5094702‏
996 ‎‡2 DBC|87097946125401‏
996 ‎‡2 ISNI|0000000078083134‏
996 ‎‡2 J9U|987011426823705171‏
996 ‎‡2 J9U|987007329908105171‏
996 ‎‡2 DNB|1205980954‏
996 ‎‡2 LC|no2010070358‏
996 ‎‡2 SUDOC|235429015‏
996 ‎‡2 W2Z|1593520723521‏
996 ‎‡2 BNF|15549496‏
996 ‎‡2 ISNI|0000000109280078‏
996 ‎‡2 PTBNP|1850689‏
996 ‎‡2 NUKAT|n 95019462‏
996 ‎‡2 CAOONL|ncf12117747‏
996 ‎‡2 LC|nb2010022836‏
996 ‎‡2 B2Q|0000830508‏
996 ‎‡2 ISNI|0000000046798995‏
996 ‎‡2 SUDOC|150902441‏
996 ‎‡2 LC|n 2015022653‏
996 ‎‡2 J9U|987007333031605171‏
996 ‎‡2 NTA|36276784X‏
996 ‎‡2 LC|n 2002153893‏
996 ‎‡2 LC|n 88619284‏
996 ‎‡2 DBC|87097939314495‏
996 ‎‡2 ISNI|0000000423178530‏
996 ‎‡2 LC|no2021153934‏
996 ‎‡2 ISNI|0000000397642001‏
996 ‎‡2 J9U|987007441065605171‏
996 ‎‡2 J9U|987007604231505171‏
996 ‎‡2 LC|no2019143846‏
996 ‎‡2 LC|no 89005242‏
996 ‎‡2 ISNI|0000000475354364‏
996 ‎‡2 SUDOC|188572929‏
996 ‎‡2 NTA|072032979‏
996 ‎‡2 ISNI|000000003315965X‏
996 ‎‡2 SUDOC|270789650‏
996 ‎‡2 LC|n 93018309‏
996 ‎‡2 BNF|17705516‏
996 ‎‡2 LC|no2013045187‏
996 ‎‡2 LC|no2023001763‏
996 ‎‡2 LC|no2015080090‏
996 ‎‡2 ISNI|0000000073186599‏
996 ‎‡2 NUKAT|nx2023799720‏
996 ‎‡2 BNF|16815100‏
996 ‎‡2 J9U|987007314602605171‏
996 ‎‡2 SIMACOB|15276643‏
996 ‎‡2 NDL|001137286‏
996 ‎‡2 LC|n 82074815‏
996 ‎‡2 DNB|1024133001‏
996 ‎‡2 LC|n 88059932‏
996 ‎‡2 NUKAT|n 2012156088‏
996 ‎‡2 BIBSYS|90389147‏
996 ‎‡2 BIBSYS|14070215‏
996 ‎‡2 NII|DA00840566‏
996 ‎‡2 LC|no2004067994‏
996 ‎‡2 ISNI|0000000108567528‏
996 ‎‡2 ISNI|0000000443615881‏
996 ‎‡2 LC|no2006043539‏
996 ‎‡2 NSK|000666586‏
996 ‎‡2 LIH|LNB:DJI_c_;=BQ‏
996 ‎‡2 NLA|000035844431‏
996 ‎‡2 BIBSYS|13026601‏
996 ‎‡2 BNC|981061014470606706‏
996 ‎‡2 NTA|301407517‏
996 ‎‡2 LC|n 2016011006‏
996 ‎‡2 DNB|1173943129‏
996 ‎‡2 SUDOC|259144436‏
996 ‎‡2 LC|n 2008028687‏
996 ‎‡2 LC|n 92054168‏
996 ‎‡2 NII|DA15293660‏
996 ‎‡2 DNB|1257925008‏
996 ‎‡2 LC|n 90695087‏
996 ‎‡2 BIBSYS|8057569‏
996 ‎‡2 DNB|1249781116‏
996 ‎‡2 DNB|1209714957‏
996 ‎‡2 LC|n 2005060784‏
996 ‎‡2 NKC|jcu20221169451‏
996 ‎‡2 NTA|422502596‏
996 ‎‡2 PTBNP|1794838‏
996 ‎‡2 SUDOC|251366014‏
996 ‎‡2 NII|DA14828015‏
996 ‎‡2 NTA|433886382‏
996 ‎‡2 NKC|utb2014802046‏
996 ‎‡2 CAOONL|ncf11609238‏
996 ‎‡2 BIBSYS|12039299‏
996 ‎‡2 LC|no2022026705‏
996 ‎‡2 ISNI|000000003141627X‏
996 ‎‡2 LC|n 88189690‏
996 ‎‡2 BIBSYS|90510095‏
996 ‎‡2 LC|n 90658040‏
996 ‎‡2 BNF|12252162‏
996 ‎‡2 ISNI|0000000045716003‏
996 ‎‡2 ISNI|000000007775061X‏
996 ‎‡2 ISNI|0000000115919237‏
996 ‎‡2 PTBNP|631283‏
996 ‎‡2 LC|n 2022013688‏
996 ‎‡2 J9U|987007263536505171‏
996 ‎‡2 NTA|07511657X‏
996 ‎‡2 RERO|A025793817‏
996 ‎‡2 LC|n 88616165‏
996 ‎‡2 BNF|12281831‏
996 ‎‡2 NTA|080269575‏
996 ‎‡2 NII|DA02111170‏
996 ‎‡2 LC|nb2023009728‏
996 ‎‡2 ISNI|0000000447964720‏
996 ‎‡2 ISNI|0000000027574515‏
996 ‎‡2 J9U|987007419230605171‏
996 ‎‡2 LC|n 2014075293‏
996 ‎‡2 LC|no2010076252‏
996 ‎‡2 CAOONL|ncf10286525‏
996 ‎‡2 NII|DA15863689‏
996 ‎‡2 SUDOC|030231949‏
996 ‎‡2 ISNI|0000000397525841‏
996 ‎‡2 RERO|A016323349‏
996 ‎‡2 NII|DA05025552‏
996 ‎‡2 BNF|17092680‏
996 ‎‡2 BIBSYS|90252365‏
996 ‎‡2 ISNI|0000000493408688‏
996 ‎‡2 ISNI|0000000045139998‏
996 ‎‡2 DNB|1147202788‏
996 ‎‡2 NTA|436253631‏
996 ‎‡2 BNF|15539609‏
996 ‎‡2 ISNI|0000000383799104‏
996 ‎‡2 BIBSYS|90628959‏
996 ‎‡2 DNB|1075738733‏
996 ‎‡2 JPG|500078427‏
996 ‎‡2 LC|n 85386006‏
996 ‎‡2 J9U|987007441332905171‏
996 ‎‡2 BLBNB|001584686‏
996 ‎‡2 BIBSYS|90352260‏
996 ‎‡2 J9U|987007371918905171‏
996 ‎‡2 J9U|987012851543505171‏
996 ‎‡2 NII|DA01097438‏
996 ‎‡2 CAOONL|ncf11464104‏
996 ‎‡2 LC|n 79052699‏
996 ‎‡2 SUDOC|059409800‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏